Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

GHX Gains New Majority Owner

Temasek, a private equity fund based in Singapore, is gaining majority ownership of GHX. Financial details were not disclosed, but Thoma Bravo, the private equity firm that acquired GHX in 2014, will remain a minority owner. The current senior management team will continue to lead GHX.

A particularly important focus for GHX in the past several years has been the implementation of Unique Device Identification or UDI on orthopaedic and other medical devices, as FDA has released guidelines and enacted its enforcement. UDI has become integral to orthopaedic companies' daily business, and therefore an critical topic for OMTEC education. GHX has served as an expert at OMTEC in years past, and due to UDI’s broad-reaching impact, it remains on the present educational agenda.

GHX is a Colorado-based hospital supply chain technology company that was founded in 2000 by General Electric, Johnson & Johnson, Abbott, Baxter and Medtronic to reduce inefficiencies in the healthcare supply chain. With a presence in the U.S., Canada and Europe, GHX connects the health industry’s providers, suppliers, distributors and group purchasing organizations, enabling them to improve their business processes and achieve greater automation.